Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging

NCT05866679 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT05866679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05866679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Suspended
Start date
April 12, 2024
Completion date
August 31, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer